)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Imricor Medical Systems
Imricor Medical Systems (IMR) investor relations material
Imricor Medical Systems Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary12 Nov, 2026
Executive summary
U.S. commercial launch began with Rady Children’s Hospital-San Diego; Children’s Medical Center Dallas purchased NorthStar two weeks later, with installation after quarter-end.
The platform combines MR-compatible equipment, guidance software and single-use catheters for real-time MR-guided cardiac procedures.
Philips compatibility, a joint turnkey iMR lab solution and DLL financing broaden hospital access.
Financial highlights
Q3 revenue was US$188k versus US$35k in Q3 CY2025, up 437%, driven by the initial U.S. NorthStar sale and installation at Rady Children’s.
Net loss was US$2.91m versus US$3.49m, down 17%; underlying net loss was US$7.65m, reflecting exclusion of non-cash fair-value adjustments.
Cash and cash equivalents were US$62.1m at September 30; operating cash outflow was US$7.33m for the quarter.
Inventory rose to US$2.6m from US$1.5m at year-end, reflecting stock secured ahead of the U.S. launch.
Outlook and guidance
CY2026 priorities include converting the U.S. hospital pipeline into NorthStar sales and scaling the U.S. commercial organisation; Dallas revenue is expected in Q4.
Initial NorthStar sales revenue is expected to exceed total European business revenue from CY2025.
Additional capital equipment clearances, including the Advantage-MR EP Recorder / Stimulator, are expected to broaden the U.S. offering.
Priorities include completing the VISABL-AFL trial, submitting the final PMA module and preparing for the FDA manufacturing pre-approval inspection.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Imricor Medical Systems
- U.S. launch, FDA clearances, and strong cash set stage for growth despite lower Q2 revenue.IMR
H1 2026 - Director elections, incentive plans, and auditor ratification passed with strong support; results pending.IMRAGM 2026
- A$60m placement funds global scale-up of MRI-guided cardiac ablation platform and clinical expansion.IMRInvestor presentation
- Major U.S. regulatory wins and clinical expansion drive commercial momentum, with strong funding position.IMRQ1 2026 TU
- Regulatory and clinical milestones, $44M raised, and global expansion marked FY25.IMRH2 2025
- World-first MRI-guided ablations and robust cash reserves drive global expansion.IMRQ4 2025 TU
- Revenue dropped 52% and net loss widened, but cash reserves and regulatory progress remain strong.IMRH1 2025
- Revenue up 105%, net loss narrowed, and $35m AUD raised for global expansion and FDA approval.IMRH1 2024
- Revenue up 56% and regulatory progress set stage for major global expansion in 2025.IMRH2 2024
Next Imricor Medical Systems earnings date
H2 202623 Feb, 2027
Imricor Medical Systems
Next Imricor Medical Systems earnings date
H2 202623 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Imricor Medical Systems Inc. specializes in the development of innovative MRI-compatible medical devices for MRI-guided cardiac catheter ablation procedures. Their products aim to enhance the success rates and reduce the overall costs of these procedures. Key products from Imricor include the Vision-MR Ablation Catheter and the Advantage-MR EP Recorder/Stimulator, both designed for use under real-time MRI guidance to offer a safer, faster, and more effective treatment compared to traditional x-ray guided catheter ablation methods. Imricor Medical Systems Inc. is headquartered in Burnsville, Minnesota, and its shares are listed on the ASX.